Emily Lesica

Emily Lesica is an accomplished leader in OTC product development, specializing in skin, cough/cold, and OTC therapeutic areas.

With a strong background in RD team leadership, she excels in building global product pipelines, developing R&D strategies, and driving early innovation and new technology evaluations.

Her expertise extends to third-party development programs for various dosage forms, including semisolid, liquid, and oral formulations.

Emily's key strengths lie in technical team leadership, talent development, and consumer healthcare innovation.

Her educational background includes a Master's in Pharmaceutical Sciences from the University of Cincinnati, an MBA in Marketing from Fairleigh Dickinson University, and a Bachelor's in Chemistry from Saint Mary's College.

Throughout her career, Emily has held significant positions in reputable organizations such as GSK, where she served as the Development Director for the Global Wellness Category, R&D Lead and NPD Director for Medicated Skin, and New Product Development Director for Therapeutic Skin.

She also contributed her expertise at Novartis Consumer Health as the Director of Global Product Development for the Cough/Cold Category and as an Associate Director focusing on New Technologies and Product Innovation.

Prior to these roles, Emily gained valuable experience as an Associate Scientist at Johnson & Johnson.